Note: This document is a translation of a part of the original Japanese version and provided for reference purposes only. In the event of any discrepancy
between the Japanese original and this English translation, the Japanese original shall prevail.

Consolidated Financial Results
for the Six Months Ended September 30, 2023
[Japanese GAAP]
November 14, 2023
Company name: SUNCORPORATION
Stock exchange listing: Tokyo
Code number: 6736
URL: https://www.sun-denshi.co.jp
Representative: Ryusuke Utsumi
President and Representative Director
Contact: Yoshimi Kimura
Representative and Executive managing directorPhone: +81-52-756-5981
Scheduled date of filing quarterly securities report: November 14, 2023
Scheduled date of commencing dividend payments: Availability of supplementary briefing material on quarterly financial results: Yes
Schedule of quarterly financial results briefing session: Yes(Amounts of less than one million yen are rounded down.)
1. Consolidated Financial Results for the Six Months Ended September 30, 2023 (April 1, 2023 to September 30, 2023)(1) Consolidated Operating Results(% indicates changes from the previous corresponding period.)
Profit attributable toNet sales
Operating profit
Ordinary profit
owners of parent
Millions of yen% Millions of yen% Millions of yen% Millions of yen%Six months ended
September 30, 2023
4,648
(78.1)
71(4,448)(4,229)September 30, 2022
21,19535.6(1,445)
12,788
683.7
6,414
537.1
(Note) Comprehensive income:Six months ended September 30, 2023:¥(1,393) million [-%]
Six months ended September 30, 2022:¥
11,061 million [395.9%]
Basic earnings
per share
Six months ended
September 30, 2023
September 30, 2022

Diluted earnings per
shareYenYen(189.88)
270.30257.22

Note: Diluted net income per share for the second quarter of fiscal year 2024 is not shown in the above table because net income pershare was negative despite the existence of dilutive shares.

(2) Consolidated Financial Position
Total assets
Millions of yen
As ofSeptember 30, 2023
40,372
March 31, 2023
41,767(Reference) Equity: As of September 30, 2023:
As of March 31, 2023:

Net assets
Millions of yen¥¥

Capital adequacy ratio

32,30035,01332,186 million
34,908 million%

79.783.6

Note: In the first quarter of the current fiscal year, the Company finalized the provisional accounting for the business combination, andthe consolidated financial position for the fiscal year ending March 31, 2023 reflects the details of the finalization of the provisional
accounting.

―1―2. Dividends
Annual dividends
1stquarter-end

2ndquarter-end

3rdquarter-end

Yen

Yen

Yen

Yen

Yen

Fiscal year ended March 31, 2023

-

0.00

-

20.00

20.00

Fiscal year ending March 31, 2024

-0.00
---

Fiscal year ending March 31, 2024
(Forecast)Year-endTotal

Note: The dividend forecast for the fiscal year ending March 31, 2024 is currently undetermined.
3. Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2024(April 1, 2023 to March 31, 2024)(% indicates changes from the previous corresponding period.)
Net sales
Millions of yen

Operating profit%

10,000(73.3)
Full year～11,000～(70.6)(Note) Revision to the financial results forecast announced most recently:

Millions of yen

10～100No%-It is difficult to reasonably estimate the impact of changes in the fair value of contingent consideration, certain restricted stock andderivative warrant liabilities of our equity method investment Cellebrite DI Ltd. The Company has not yet determined the fair value ofthe restricted stock and derivative warrant liability.
* Notes:(1) Changes in significant subsidiaries during the six months ended September 30, 2023
(changes in specified subsidiaries resulting in changes in scope of consolidation):
No
New(Company name:(Company name:
Exclusion:(2) Accounting policies adopted specially for the preparation of quarterly consolidated financial statements:))
No(3) Changes in accounting policies, changes in accounting estimates and retrospective restatement
1) Changes in accounting policies due to the revision of accounting standards: No
2) Changes in accounting policies other than 1) above: No
3) Changes in accounting estimates: No4) Retrospective restatement: No(4) Total number of issued shares (common shares)
1) Total number of issued shares at the end of the period (including treasury shares):
September 30, 2023:
24,007,728 shares
March 31, 2023:
23,998,828 shares
2) Number of treasury shares at the end of the period:September 30, 2023:
1,794,181 shares
March 31, 2023:
1,366,387 shares
3) Average number of shares outstanding during the period:
Six months ended September 30, 2023:
Six months ended September 30, 2022:

22,272,742 shares
23,732,042 shares※

Quarterly financial statements are not subject to a quarterly review by a certified public accountant or firm of accountants.

※

Explanation of the appropriate use of earnings guidance and other special disclosures
The forward-looking statements in this document, including earnings guidance, are based on information currently available
to the Company and certain assumptions that the Company believes are reasonable. Actual results could differ materially as aresult of various factors.

―2―